Brigham and Women’s Hospital in Boston Massachusetts will soon begin Phase I trials of a nasal vaccine designed to prevent or slow the progression of Alzheimer’s disease (AD), a press release said. This is the first occasion when a nasal vaccine is being attempted for the disease, which affects more than six million people in the U.S. alone.
First seen in a patient way back in 1906 by Dr. Alois Alzheimer, the disease is a brain disorder characterized by the presence of clumps (amyloid plaques) and tangled fibers (tau tangles) between nerve cells (neurons) in the brain. Symptoms of the disease, which is usually seen in adults in their 60s, vary from memory issues to vision loss and even impaired reasoning.
The cause of the disease has long been questioned and researchers only recently believed to have come to the root of it. Research for a cure has been ongoing for decades, however, most interventions are aimed at reducing the severity of the symptoms. The vaccine to be trialed aims to change this.
The nasal vaccine trial
Howard L. Weiner, co-director of a center that studies neurological disease at Brigham has been researching the development of AD for over 20 years. Previous studies have shown that the immune cells in the body play a role in the removal of the amyloid plaques from the brain. Therefore, the researchers are using an immune modulator called Protollin to stimulate the immune system and remove the plaques.
Protollin is an intranasal agent derived by mixing specific cell components of different bacteria and is already used as an adjuvant, to generate greater immune response for other vaccines. The researchers are hopeful that by triggering the immune system, specifically the white blood cells from the lymph node located in the neck area, the vaccine will clear out plaques in AD patients too.
The trial will include 16 participants between the age of 60 and 85 years who have been diagnosed with symptomatic, early-stage AD, the press release said. Trial participants will receive two doses of the vaccine, one week apart. The main aim of the trial is to determine if the vaccine is safe and can be tolerated at the dosages planned. If successful, the same mode of treatment could be used for other neurodegenerative diseases, the press release said.
Interestingly, another possible treatment and vaccine strategy for AD was published earlier this month and will move to human trials soon.
News
New Research Reveals That Your Sense of Smell May Be Smarter Than You Think
A new study published in the Journal of Neuroscience indicates that the sense of smell is significantly influenced by cues from other senses, whereas the senses of sight and hearing are much less affected. A popular [...]
Deadly bacteria show thirst for human blood: the phenomenon of bacterial vampirism
Some of the world's deadliest bacteria seek out and feed on human blood, a newly-discovered phenomenon researchers are calling "bacterial vampirism." A team led by Washington State University researchers has found the bacteria are [...]
Organ Architects: The Remarkable Cells Shaping Our Development
Finding your way through the winding streets of certain cities can be a real challenge without a map. To orient ourselves, we rely on a variety of information, including digital maps on our phones, [...]
Novel hydrogel removes microplastics from water
Microplastics pose a great threat to human health. These tiny plastic debris can enter our bodies through the water we drink and increase the risk of illnesses. They are also an environmental hazard; found [...]
Researchers Discover New Origin of Deep Brain Waves
Understanding hippocampal activity could improve sleep and cognition therapies. Researchers from the University of California, Irvine’s biomedical engineering department have discovered a new origin for two essential brain waves—slow waves and sleep spindles—that are critical for [...]
The Lifelong Cost of Surviving COVID: Scientists Uncover Long-Term Effects
Many of the individuals released to long-term acute care facilities suffered from conditions that lasted for over a year. Researchers at UC San Francisco studied COVID-19 patients in the United States who survived some of the longest and [...]
Previously Unknown Rogue Immune Key to Chronic Viral Infections Discovered
Scientists discovered a previously unidentified rogue immune cell linked to poor antibody responses in chronic viral infections. Australian researchers have discovered a previously unknown rogue immune cell that can cause poor antibody responses in [...]
Nature’s Betrayal: Unmasking Lead Lurking in Herbal Medicine
A case of lead poisoning due to Ayurvedic medicine use demonstrates the importance of patient history in diagnosis and the need for public health collaboration to prevent similar risks. An article in CMAJ (Canadian Medical Association [...]
Frozen in Time: How a DNA Anomaly Misled Scientists for Centuries
An enormous meteor spelled doom for most dinosaurs 65 million years ago. But not all. In the aftermath of the extinction event, birds — technically dinosaurs themselves — flourished. Scientists have spent centuries trying [...]
‘Mini kidneys’ reveal new insights into metabolic defects in polycystic kidney disease
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have successfully grown 'mini kidneys' in the lab and grafted them into live mice, revealing new insights into the metabolic defects and a potential therapy for [...]
Decoding the Origin of Life: Scientists Solve Early Earth RNA Puzzle
Recent research illustrates how RNA molecules’ chemical characteristics might have played a crucial role in the development of complex life forms. How did complex life manage to evolve on the early, inhospitable Earth? Initially, [...]
Improving infectious disease testing with gold nanoparticles
By harnessing the power of composite polymer particles adorned with gold nanoparticles, a group of researchers have delivered a more accurate means of testing for infectious diseases. Details of their research was published in the [...]
New micromaterial releases nanoparticles that selectively destroy cancer cells
Researchers have developed micromaterials made up only of proteins, capable of delivering over an extended period of time nanoparticles that attack specific cancer cells and destroy them. The micromaterials mimic natural secretory granules found [...]
Alzheimer’s Breakthrough: Scientists Make Revolutionary Leap
Dementia is a major health issue worldwide in the 21st century, impacting over 50 million people globally. This figure is expected to soar to 152 million by 2050, as the global population ages. Alzheimer’s disease (AD) [...]
How small RNA molecules regulate viral infections of bacteria
Viruses need hosts. Whether it's measles, the flu or coronavirus, viral pathogens cannot multiply or infect other organisms without the assistance of their hosts' cellular infrastructure. However, humans are not the only ones affected [...]
Computer scientists discover gap in the latest security mechanisms used by some chips
Over the past few years, hardware manufacturers have developed technologies that ought to make it possible for companies and governmental organizations to process sensitive data securely using shared cloud computing resources. Known as confidential [...]
